Format

Send to:

Choose Destination
See comment in PubMed Commons below
Prog Brain Res. 2012;201:79-98. doi: 10.1016/B978-0-444-59544-7.00005-6.

Bone marrow stem cells in experimental stroke.

Author information

  • 1Department of Neurology, Yale University, School of Medicine, New Haven, CT, USA. jeffery.kocsis@yale.edu

Abstract

Adult bone marrow-derived mesenchymal stem cells (MSCs) have a remarkable spectrum of functional properties. Transplantation of MSCs improves clinical outcome in animal models of cerebral ischemia, and traumatic brain and spinal cord injury, via mechanisms that may include induction of axonal sprouting and remyelination, protection of injured neurons, neovascularization, and, potentially, replacement of damaged cells. Beneficial therapeutic effects have been reported in experimental models of stroke following intravenous delivery of MSCs. Initial clinical studies using intravenously delivered MSCs have been initiated in human subjects with stroke. This chapter reviews multiple beneficial effects of MSCs in experimental stroke models, describes initial human clinical studies on intravenous MSC delivery in stroke, and provides a perspective on further experimental and clinical studies of MSCs.

Copyright © 2012 Elsevier B.V. All rights reserved.

PMID:
23186711
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk